CHRISTUS Health selects Acuo UCP3 as new vendor neutral archive solution

NewsGuard 100/100 Score

Acuo Technologies®, the leader in high-performance software and services for intelligent medical image lifecycle management and data migration, announced today that CHRISTUS Health has selected the Universal Clinical Platform (UCP3) as the company's new vendor neutral archive solution. UCP3 will replace CHRISTUS' existing PACS archives while providing an enterprise foundation for future on-premise and cloud-based clinical content management.

UCP3 will provide CHRISTUS Health with better access to all imaging data and a comprehensive solution for facility, partner and physician affiliation, while allowing the company to retire more expensive imaging archive systems across its facilities. UCP3 enables CHRISTUS to preserve its investment in existing PACS technology and storage assets, while providing an easier and more economical path for replacement of these systems when the time is right.

"We are pleased to be working with one of the country's largest and most respected integrated delivery networks," said Jeff Timbrook, CEO of Acuo Technologies.  "It was clear during the evaluation process that CHRISTUS Health leaders, clinicians and technologists share Acuo's vision of the next generation of image management systems that are focused on delivering superior patient care while reducing costs throughout the enterprise."

"CHRISTUS Health partnered with Acuo Technologies after a thorough evaluation of the top VNA middleware suppliers," said George Conklin, CIO of CHRISTUS Health. "It was clear from the very start that Acuo's level of expertise in this type of technology was solid. Their team truly understands how to improve and simplify what has up until now been a very complex problem for health care providers. Their UCP3 product will give us the flexibility to deploy technology in a way that meets the needs of those we serve."

Source:

Acuo Technologies

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Do deep learning tools outperform humans in diagnosing breast cancer via ultrasound imaging?